Let Worldwide Make a World of Difference
for You
Having trouble narrowing down your CRO options? Clinical Leader announced the 2024 Leadership Awards, supported by data from ISR Reports, naming Worldwide Clinical Trials the highest-rated Phase I Service Provider for Overall User Preference and the highest-rated Ph II/III CRO for Overall Performance.
Access the reports by filling out the form!
Worldwide achieved top marks from sponsor companies demonstrating comprehensive excellence in:
Overall
Big Pharma
Overall
Big Pharma
Small Pharma
Overall
Big Pharma
Small Pharma
Overall
Big Pharma
Small Pharma
Overall
Big Pharma
Small Pharma
Additionally, Worldwide was honored as a Champion in:
Compatibility (Big Pharma)
Expertise (Big Pharma)
Quality (Big Pharma)
Reliability (Big Pharma)
Why Benchmarking Matters in 2024
Over the past several years, we have seen enormous growth in the pharma industry. Many companies outsource their clinical development programs to CROs, but finding the right fit — and ensuring they can meet expectations—is a time-consuming, labor-intensive task better outsourced to experts. ISR’s annual report is a reliable resource that takes the guesswork and stress out of the process, enabling companies to make decisions informed by data and independent performance evaluation.
Phase I Participant Methodology
- Data for this study was collected in Q4, 2023.
- 169 respondents from North America, Europe, Asia-Pacific, and Latin America participated in this 30-minute web-based quantitative survey.
- Must work at a large biopharma, midsize biopharma, or small biopharma.
- Must have responsibility in at least one of several relevant areas such as Clinical Operations and Project Management, R&D Management, Executive Management, Outsourcing/Purchasing Management, Clinical Operations, Data Management, Biostatistics, and Medical Writing.
- Must have involvement with outsourced Ph I trials within past 12 months.
Phase II/III Participant Methodology
- Data for this study was collected in Q4, 2023.
- 232 respondents from North America, Europe, Asia-Pacific, and Latin America participated in this 30-minute, web-based quantitative survey.
- 824 service encounters were captured.
Respondents were required to pass several screening criteria to qualify and participate in this survey:
- Must work at a pharmaceutical company, biotech company, or medical device company
- Must have responsibility in at least one of several relevant areas such as Clinical Operations, Project Management, Executive Management, Medical, Outsourcing/Procurement, or Research and Development Management
- Must have involvement with outsourced Phase 2/3 trials within past 12 months
About Us
We are a leading full-service global CRO founded on the premise that attention and accessibility make healthcare better. Our tailored approach has turned that premise into a promise to our partners, ensuring they have the best possible outcomes.
Always Accessible
We’re your extended team, and we’re always within reach. That means being where you need us when you need us, including our senior-level experts, who will work directly with you.
Always Dedicated
We believe working together to harness great ideas will lead us to a healthier world. Every study is different, and every path forward is different, but we will partner with you every step of the way.
Always Personalized
We were founded on an unwavering commitment to therapeutic excellence and personalized attention. And today, that commitment is more important than ever.
Therapeutic Experts
Locations
Countries, All Regions
Worldwide named one of the leading CRO providers
Representing the company’s longest-standing studies, ISR’s CRO Benchmarking reports leverage years of industry experience. The results offer clarity and transparency, helping organizations make informed CRO selection decisions.